Skip to main content

Bin Zhang

FY2026 NIH rank #4,903
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9752916Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-6631-7647Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Internal Medicine
  • Neurosciences
  • ENGINEERING (ALL TYPES)

NIH Funding · FY2026

Linked Award Amount
$3.5M
Full award amounts, FY2026
Award Records
6
Records listing this PI
Award-Linked Rank
#4,903
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bin Zhang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$3.1M

5 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Bin Zhang as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA258857-06R01
    Targeting posttranslational modifications of CD73 in TNBCs
    $668.4K
    award amount
  • 5R01CA290743-03R01
    Sustaining antitumor effector CD8+ T cells for cancer therapy
    $661.7K
    award amount
  • 1R01CA303489-01A1R01
    Engineering Immunostimulatory Spherical Nucleic Acids for B cell adoptive therapy
    $660.5K
    award amount
  • 2R01CA224275-06A1R01
    Lipid Unsaturation Drives Ovarian Cancer Progression
    $641.1K
    award amount
  • 5R01CA257926-05R01
    Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
    $511K
    award amount
  • 7R01CA257926-06R01
    Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
    $343.9K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Bin Zhang as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Northwestern University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3172
  6. 2024
    Entered Top 25% Nationally
    Ranked #3172
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  9. 2025
    R01 Grant Holder
Bin Zhang | NIH Award Records | ConductScience